top of page
​BioFinland Member

BioFinland Member

Herantis Pharma Plc

Herantis Pharma Plc
Company name

Herantis Pharma Plc


Bertel Jungin aukio 1, FI-02600 Espoo


+358 9 222 1195





Contact person

antti.vuolanto at


Antti Vuolanto

Main categories

Drug Discovery and Development / Drug Delivery, Pharmaceutical

Last updated

5 February 2019

Company profile

Herantis Pharma Plc is an innovative drug development company focused on regenerative medicine and unmet clinical needs. Our clinical stage assets CDNF and Lymfactin® are based on globally leading scientific research in their fields. They both aim at breakthrough in the treatment of severe diseases: CDNF in neurodegenerative diseases such as Parkinson’s disease; and Lymfactin® in breast cancer associated lymphedema with potential also in other lymphedemas. The shares of Herantis are listed on the First North Finland marketplace run by Nasdaq Helsinki stock exchange.

bottom of page